← Back to Search

Topical Agent

GT20029 Gel for Acne

Phase 1
Waitlist Available
Research Sponsored by Suzhou Kintor Pharmaceutical Inc,
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up stage 1 is about 22 days and stage 2 is about 35 days
Awards & highlights

Study Summary

This trial is testing a new drug for safety, tolerability, and how it is metabolized in healthy subjects and subjects with androgenetic alopecia or acne.

Eligible Conditions
  • Acne
  • Male Pattern Baldness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~stage 1 is about 22 days and stage 2 is about 35 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and stage 1 is about 22 days and stage 2 is about 35 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse event
Skin irritation assessments
To characterize the PK AUC of GT20029
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: GT20029Experimental Treatment1 Intervention
Group II: GT20029 PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GT20029 Gel
2022
Completed Phase 1
~130

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Suzhou Kintor Pharmaceutical Inc,Lead Sponsor
14 Previous Clinical Trials
2,720 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there availability for volunteers to join this research endeavor?

"Per the data available on clinicaltrials.gov, patient recruitment for this medical trial is ongoing. It was initially posted on February 10th 2022 and its details were last modified on June 16th of that same year."

Answered by AI

Is there a possibility for me to be involved in this clinical exploration?

"To be eligible for this medical experiment, applicants must suffer from acne and fit within the age parameters of 18 to 60 years. The endeavor is currently recruiting approximately 152 participants."

Answered by AI

Has the FDA greenlighted GT20029 Gel for commercial use?

"Due to the preliminary nature of this trial, our team at Power has assigned GT20029 Gel a score of 1 in terms of safety. This is because Phase 1 trials provide limited data concerning both efficacy and safety."

Answered by AI

Are seniors permitted to participate in the trial?

"Based on the predetermined requirements for this clinical trial, participants must be 18 years old or above and no older than 60."

Answered by AI

How many people are enrolled in this research endeavor?

"Affirmative. According to clinicaltrials.gov, this medical study which was first posted on February 10th 2022 is actively recruiting participants. The protocol requires 152 individuals from 2 separate sites for the trial's completion."

Answered by AI

Who else is applying?

What state do they live in?
New York
Louisiana
Pennsylvania
Other
How old are they?
18 - 65
What site did they apply to?
JBR Clinical Research Sharp
Velocity San Diego
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
1
3+
0
2

Why did patients apply to this trial?

Finding cure for hair loss. I want to cure my hair loss. I have tried many drug like finstrirs but not work.
PatientReceived 1 prior treatment
I want to see if it can cure other people's baldness. Prove minoxidil y finasteride espero que este sea mas eficaz.
PatientReceived 2+ prior treatments

What questions have other patients asked about this trial?

Is this a randomized trial? When would I receive treatment during the week?
PatientReceived 1 prior treatment

How responsive is this trial?

Most responsive sites:
  1. Velocity San Diego: < 48 hours
Typically responds via
Phone Call
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029
2022. "Study in Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of GT20029". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05428449.
~39 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top